Do you want to read an article? Please log in or register.
Risk of Ocular Hypertension in Adults with Noninfectious Uveitis
Glaucoma and Ocular PressureRetinal DiseasesUveitis
Related content
Uveitis
Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative
Ophthalmology.
Dick AD, Rosenbaum JT, Al-Dhibi HA, Belfort R Jr., Brézin AP, Chee SP, Davis JL, Ramanan AV, Sonoda KH, Carreño E, Nascimento H, Salah S, Salek S, Siak J, Steeples L; Fundamentals of Care for Uveitis International Consensus Group
doi: 10.1016/j.ophtha.2017.11.017.
Glaucoma and Ocular Pressure
Uveitis and cystoid macular oedema secondary to topical prostaglandin analogue use in ocular hypertension and open angle glaucoma
Br J Ophthalmol.
Hu J, Vu JT, Hong B, Gottlieb C
doi: 10.1136/bjophthalmol-2019-315280.
Uveitis
Effect of Adalimumab on Visual Functioning in Patients With Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis in the VISUAL-1 and VISUAL-2 Trials
JAMA Ophthalmol.
Sheppard J, Joshi A, Betts KA, Hudgens S, Tari S, Chen N, Skup M, Dick AD
Uveitis
Efficacy and Safety of Intravitreal Sirolimus for Noninfectious Uveitis of the Posterior Segment: Results from the Sirolimus Study Assessing Double-Masked Uveitis Treatment (SAKURA) Program
Ophthalmology.
Merrill PT, Clark WL, Banker AS, Fardeau C, Franco P, LeHoang P, Ohno S, Rathinam SR, Ali Y, Mudumba S, Shams N, Nguyen QD, Sirolimus Study Assessing Double-Masked Uveitis Treatment (SAKURA) Study Group.
doi: 10.1016/j.ophtha.2020.03.033.
Uveitis
Adalimumab in Patients with Active Noninfectious Uveitis
N Engl J Med.
Jaffe GJ, Dick AD, Brézin AP, Nguyen QD, Thorne JE, Kestelyn P, Barisani-Asenbauer T, Franco P, Heiligenhaus A, Scales D, Chu DS, Camez A, Kwatra NV, Song AP, Kron M, Tari S, Suhler EB
doi: 10.1056/
UveitisFurther Publications
Corneal Endothelial Transplantation in Uveitis: Incidence and Risk Factors
Am J Ophthalmol
Roldan AM, Zebardast N, Pistilli M, Khachatryan N, Payal A, Begum H, Artornsombudh P, Pujari SS, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Buchanich JM, Kempen JH, Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study Research Group.
doi: 10.1016/j.ajo.2021.10.031
RECOMMENDED
Glaucoma and Ocular Pressure
Prevalence, risk factors and management of ocular hypertension or glaucoma in patients with Vogt-Koyanagi-Harada disease
★ 2
Recommended by
Dr Katarzyna Konieczka, Faculty Member
Br J Ophthalmol
Yang P, Wang C, Su G, Pan S, Qin Y, Zhang J, Cao Q, Zhong Z, Zhou C, Wang Y, Kijlstra A
doi: 10.1136/bjophthalmol-2020-316323
Uveitis
Long-Term Outcomes of Treatment with Biological Agents in Eyes with Refractory, Active, Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis
Ophthalmology.
Al-Janabi A, El Nokrashy A, Sharief L, Nagendran V, Lightman S, Tomkins-Netzer O
doi: 10.1016/j.ophtha.2019.08.031.
RECOMMENDED
Uveitis
Association Between Noninfectious Uveitis and Psychological Stress
JAMA Ophthalmol.
Berlinberg EJ, Gonzales JA, Doan T, Acharya NR
doi: 10.1001/jamaophthalmol.